Clin2
NCT05588323Possibly a fitRecruiting

Testing naldemedine for constipation caused by opioid pain meds

Opioid-Induced Constipation (OIC)

Part of Mental health clinical trials.

This study tests whether naldemedine is safe and how the body processes it in children who take opioid medicines and are dealing with constipation or are at risk for it. It may help some children by reducing constipation side effects from opioid pain treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
24 people
Ages
2 years to 18 years
Study type
Interventional

Who can take part

  • You have cancer or non-cancer pain and you are taking opioids now or about to start them
  • You have constipation that is new, or a past history of constipation treated with laxatives, or constipation is expected after opioids
  • You (or your child) can stay at the clinic for blood draws for at least 12 hours after the first dose, and return at 24 hours
  • Child’s growth is within a healthy range for age (BMI roughly the 3rd to 97th percentiles)
  • You do not have a recent or planned surgery in the gut (within the last year for past surgery, or upcoming surgery)
  • You do not have signs of a blocked or perforation-risk gut (for example, obstruction) and can eat or swallow normally

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07231796Recruiting
Study of naldemedine for opioid-induced constipation in cancer patients

This trial tests whether naldemedine, a medication for constipation, can help cancer patients who have constipation caused by opioids. It looks at how well it works and how patients feel.

Amsterdam
NCT03720613Recruiting
Testing medicines to prevent heart events in opioid constipation

This study looks at how well naldemedine (and certain other constipation medicines) lower the risk of major heart problems in people who take opioids for constipation. It compares medicine use patterns in people with opioid-induced constipation to see who has fewer serious heart events.

Wilmington, Delaware
NCT05216328Recruiting· Phase 4
Preventing opioid-related constipation in advanced cancer

This trial tests whether starting a laxative right away can prevent constipation caused by pain medications called opioids. It's for people with advanced cancer who are beginning opioid pain treatment and aims to improve comfort and quality of life.

Almere Stad, Flevoland
NCT07534995Not yet recruiting· Phase 3
Treatment for opioid-induced constipation in people with cancer

This trial tests a new treatment for constipation caused by opioid pain medication. It aims to see if it's safe and effective, and may help you have more regular bowel movements.

NCT06897917Not yet recruiting· Phase 4
A pain pill that may reduce constipation for severe cancer pain

This study tests a combination pill (oxycodone with naloxone) that may treat severe cancer pain while also helping with constipation — a common side effect of opioid pain medicines. It is designed for people whose constipation is linked to their painkillers.

Zhengzhou, Henan
NCT07650812Not yet recruiting
Painkiller for stomach function after brain tumor surgery

This study tests a new painkiller called oliceridine to see if it helps the stomach and intestines work normally after brain surgery. It is for people having surgery to remove a brain tumor, with the goal of reducing problems like nausea or constipation after the operation.

Hear when a new Opioid-Induced Constipation (OIC) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.